ArticleClinical ophthalmology (Auckland, N.Z.)2019

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration.

Naoko Koike et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.